|
HPV oncogenes | siRNA design | Biological effects | References |
|
HPV16 E6 and E7 | Synthetic siRNA | Silencing of HPV16 E6 and E7, p53, p21 and pRb expression. Apoptosis induction in vitro. | [72] |
HPV16 E6 | Synthetic siRNA | Silencing of HPV16 E and E7, p53, p21 and pRb expression. Cellular proliferation inhibition in vitro. Tumor growth inhibition in vivo. | [73] |
HPV18 E6 | Synthetic siRNA | Silencing of HPV16 E6, p53, p21, and pRb expression. Apoptosis induction in vitro. | [74] |
HPV16 E7 | Synthetic siRNA in bio-adhesive gels | Silencing of HPV16 E7. Apoptosis induction in vitro. | [87] |
HPV18 E6 and E7 | Synthetic siRNA with chemotherapy | Silencing of HPV18 E6 and E7, as well as p53 expression. Cytotoxicity decrease in vitro. | [94] |
HPV18 E6 | siRNA in lentivirus with chemotherapy | Silencing of HPV18 E6 and E7, as well as p53 expression. Cytotoxicity decrease in vitro. | [86] |
HPV16 E6 and E7 | Synthetic siRNA in liposomes | Silencing of HPV16 E6 and E7. Apoptosis induction in vitro. Tumor growth inhibition in vivo. | [88] |
HPV18 E6 and E7 | siRNA with atelocollagen | Silencing of HPV18 E6 and E7, as well as p53 and pRb expression. Cellular senescence induction in vitro. Tumor growth inhibition in vivo. | [89] |
HPV18 E6 and E7 | Synthetic siRNA | Silencing of HPV18 E6 and E7 and cyclin A gene, as well as p53, pRb, p16, p21, and p27 expression. Apoptosis induction in vitro. | [75] |
HPV18 E6 and E7 | siRNA in pSUPER plasmid | Silencing of HPV16 E6 and E7, as well as p53 and pRb expression. Transcriptome expression analysis of cancer cells. | [91] |
HPV16 E6 and E7 | siRNA in psiCheck 2 plasmid | Silencing of HPV16 E6 and E7, as well as p53 and p21 expression. Cellular senescence induction in vitro. Tumor growth inhibition in vivo. | [95] |
HPV16 E7 | siRNA in pSIRE-DNR plasmid | Silencing of HPV E6 and E7, as well as p53, p21 and pRb expression. Apoptosis induction in vitro. | [96] |
High risk HPV E6 and E7 | siRNA in lentivirus | Silencing of HPV16 E6 and E7. p53 and p21 expression. Apoptosis induction in vitro and in vivo. High efficiency of infection of proliferation cells and quiescent cells. | [90] |
HPV16 E6 and E7 | siRNA in pSilencer 1.0U6-plasmid | Silencing of HPV16 E6 and E7. p53 and pRb expression. Cellular proliferation inhibition. Autophagic and apoptosis induction of tumor cells in vivo. | [97] |
|